Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external evaluation.” So far, just 130 cases have been completed in the U.S. since the company received U.S. FDA approval in November for use in paroxysmal atrial fibrillation. Read More

Fire1 Ltd. secured $120 million in financing to conduct a pivotal trial for its heart failure management system, Norm. The technology measures fluid in the inferior vena cava (IVC) and is expected to help the millions of people living with heart failure manage their condition and get their normal life back. Read More

Women with endometriosis may soon be able to have a simple blood test to diagnose their disease thanks to a breakthrough by Proteomics International Ltd. that has developed a plasma protein biomarker panel that identifies all stages of endometriosis. Read More

2024 saw the completion of several cellular-resolution brain maps, including the entire fly brain and a comprehensive connections map of a cubic centimeter of human brain. 2025 began with the addition of another important map. In the Jan. 1, 2025, issue of Nature, researchers from the Allen Institute presented a map of areas and cell types where aging most affected the mouse brain. Read More

BioWorld MedTech’s staff recaps the med-tech and diagnostic trends and breakthroughs of 2024, the financing trends of the past year and the regulatory actions likely to affect med-tech into 2025. Read More

Taking a look back at the achievements in research this year, including brain maps, pandemic breakthroughs and advances in pregnancy health. Read More

BioWorld’s staff recaps the therapeutic trends and breakthroughs of 2024, the economic highs and lows facing the industry throughout the past year and the regulatory actions that are likely to have implications as biopharma forges ahead in 2025. Read More

New hires and promotions in the med-tech industry, including: Eyenuk, Livanova, Lumicell, Perspective Therapeutics. Read More

Med-tech firms raising money in public or private financings, including: Inify Laboratories, Lifeward, Oxford Cancer Analytics, Zeto. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Implantica. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerwave, Argon Medical, Biofidelity, Biostem, Caresyntax, Cellcarta, Endostream, Genialis, Inify, Kaneka, Peerbridge, Qaelon, Roivios, Tempus AI, Tricares. Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carestream, Fesariustherapeutics, Oxos, Roche, Ventris. Read More